2013 Archive

November 30, 2013

Curhan

Brigham Board Review Course    Boston, MA; August, 2012 Kidney Stone Cases Gary C. Curhan, MD

Testai   Gamaldo   Biller   Vickrey

American Society of Hypertension Annual Scientific Meeting (Part 1)    San Francisco, CA; May 2013 Hypertension, Diabetes and Cognitive Function Fernando Testai, MD Role of Sleep Disorders in Stroke Charlene Gamaldo, MD Use of Anticoagulation in Stroke Prevention Jose Biller, MD Secondary Stroke Prevention Barbara Vickrey, MD

Beathard   Lok   Niyyar   Falk   Ross   Shenoy   Fox   Yevzlin   Pflederer

ASDIN Annual Scientific Meeting (Parts 7-10)    Washington, DC; February, 2013 PART 7 JOURNAL CLUB: HOT TOPICS IN THE LITERATURE Stent Graft and 180 day patency result Gerald A. Beathard, MD Fish Oil to Increase AVG patency Charmaine E. Lok, MD Anti-microbial locks increase bacterema Vandana Dua Niyyar, MD PART 8 POINT COUNTERPOINT Surgical Management is Ideal for Aneurysm/Pseudoaneurysm John R. Ross, MD Stent Graft Should Be Attempted Before Surgical Referral for Aneurysm/Pseudoaneurysm Abigail Falk, MD PART 9 VASCULAR ACCESS PLACEMENT IN THE MEDICALLY CHALLENGED PATIENT Access Placement in the Patient With Central Venous Occlusion Surendra Shenoy, MD Ipsilateral Access After Axillary Lymph Node Dissection David Fox, MD Ipsilateral Access in the Atrophied Limb Surendra Shenoy, MD PART 10 ASDIN AWARDS Presentation Gerald Beathard Award - awarded to Charmaine E. Lok, MD Alex S. Yevzlin, MD ASDIN Distinguish Service Award - awarded to Timothy A. Pflederer, MD Gerald Beathard, MD

Annual Dialysis Conference 2013 now in MP3

AUDIOFILE LIST (Annual Dialysis Conference 2013) Mini-symposium on Transitioning the Adolescent Dialysis Patient to an Adult Dialysis Program Lorraine Bell, MD, Beth Piraino, MD, and Seattle Patients; 3 talks Symposium on the Adolescent Dialysis Patient: Part I Cora Breuner MD; 1 talk Peritoneal Dialysis Program Management Beth Piraino, MD, Fredric Finkelstein, MD, John Burkart, MD, and John Burkart, MD; 4 talks Step-By-Step Approach to Optimal Preparation of Patients for Dialysis Bessie Young, MD, Leanna Tyshler, Scott Bieber, DO, and Rajnish Mehrotra, MD; 4 talks Clinical Nephrology II: Joint Nursing and Nutrition Session Robert Martindale, MD, Linda McCann, RD, and Marisa Juarez, RD; 3 talks Anticoagulation in 2013 Andrew Davenport, MD, Robert Reilly, MD, and Suhail Ahmad, MD; 3 talks

October 31, 2013

Mount   Hsiao

Brigham Board Review Course    Boston, MA; August, 2012 Hypokalemia and Hyperkalemia David B. Mount, MD Interstitial Nephritis: An Overview for the Boards Li-Li Hsiao, MD

Passman   Thijssen   Tentori

Advances in CKD 2013 (Part 9 - last section)    Renal Research Institute Rio Grande, Puerto Rico; January, 2013 Keynote Address: Prevention of sudden cardiac death in dialysis patients: drugs, defibrillators or what else? Rod Passman, MD Blood volume in hemodialysis—absolute or relative measurements and how to use them Stephan Thijssen, MD Diastolic function in CKD: Diagnosis and relevance for outcomes Francesca Tentori

Saad   Vesely   Rajan   Falk   Haskal   Miller   Work   Asif   Roy-Chaudhury   Paulson   LeDonne   Shenoy

ASDIN Annual Scientific Meeting (Parts 4-6)    Washington, DC; February, 2013 PART 4 ACCESS SELECTION AND PRESERVATION Access Selection in Failed Transplant Recipients Prabir Roy-Chaudhury Ongoing Controversies in Dialysis Vascular Access Surveillance William D. Paulson, MD Fundamentals of Arterial and Venous Angioplasty Thomas M. Vesely, MD Vascular Access in the CKD Patient (and the General Public) Jack Le Donne MD Alternative Vascular Access for patient who has "used up everything" Surendra Shenoy MD PART 5 POINT COUNTERPOINT PTA is the Best Therapy for Cephalic Arch and Central Vein Stenosis Ziv J. Haskal, MD Stent Graft Placement is Best for Cephalic Arch and Central Veni Stenosis Dheeraj K. Rajan, MD Patients should return for scheduled follow up after access intervention Gregg A Miller, MD Patients Should NOT Have Scheduled Follow up after access intervention Jack Work, MD Stenting Over Transvenous CIED Leads Is Acceptable for Recurrent Patients Theodore F. Saad, MD Stenting Over Transvenous CIED Leads Should Never be Considered...EVER Arif Asif, MD PART 6 NUTS AND BOLTS OF ENDOVASCULAR INTERVENTION : Morbidity and Mortality Dealing with Venous Rupture Theodore F. Saad, MD How should I retrieve a stent? Thomas Vesely, MD How Do I remove a stuck ruptured balloon? Dheeraj Rajan, MD This Hemodialysis Catheter Won’t Come Out! Abigail Falk, MD

September 17, 2013

Mount   Kraut

Brigham Board Review Course    Boston, MA; August, 2012 Hyponatremia and Hypernatremia David B. Mount, MD Acid Base Part 1 - Acidemia Jeffrey A. Kraut, MD

Saran   Titze   Lindsay   Daugirdas

Advances in CKD 2013 (Part 8)    Renal Research Institute Rio Grande, Puerto Rico; January, 2013 National CKD Surveillance System Launch of New Website by the U.S. Centers for Disease Control & Prevention Rajiv Saran, MD Spooky sodium balance Jens Titze, MD Debate: Tight volume control accelerates loss of renal function but the price is right - YES Robert M. Lindsay, MD - NO John T. Daugirdas, MD

Pflederer   Narayan   Fox   Abreo   Ash   Urbanes

ASDIN Annual Scientific Meeting (Parts 1-3)    Washington, DC; February, 2013 PART 3: PD and Catheter Placement Increasing Access to PD for Incident Dialysis Patients Timothy A. Pflederer, MD Percutaneous Fluoroscopic Peritoneal Dialysis Catheter Insertion Rajeev Narayan, MD The Role of Surgical PD Catheter Placement in the Interventional Era David Fox, MD Urgent Start PD: The Caveats and Optimal Placement Technique Kenneth Abreo, MD PART 2: Gerald Beathard State of the Art Lecture Can Interventional Nephrology Programs Help Popularize Home Dialysis Therapies? Stephen Ash, MD PART 1: ASDIN Scientific Meeting: Welcome and President’s Address Welcome and President’s Address Aris Q. Urbanes, MD

July 31, 2013

Appel

Brigham Board Review Course    Boston, MA; August, 2012 New Data and New Questions on IgA Nephropathy Gerald B. Appel, MD

DeOreo   Benner   Golper   Ross   Daugirdas   Kotanko   Misra

ISHD Hemodialysis University (Parts 3 and 4)    Chicago, IL; September, 2012 PART 3. WATER FOR DIALYSIS AND HOME HEMODIALYSIS Water for Dialysis: Case Studies Peter DeOreo, MD, and Rich Benner, CWS III Home Hemodialysis Overview Thomas A. Golper, MD Home is where dialysis should be! Dennis Ross, MD Home HD Vascular Access and Adequacy Thomas A. Golper, MD and Dennnis Ross, MD PART 4. SODIUM AND VOLUME CONTROL Dialysate Sodium Peter Kotanko, MD Sodium and Volume control Madhukar Misra MD Determination of Dry Weight Peter Kotanko, MD Intradialytic Hypertension Madhukar Misra MD Hemodialysis Hypotension John T. Daugirdas, MD

Kaysen   Kasiske   Filho   Ward

Advances in CKD 2013 (Part 7)    Renal Research Institute Rio Grande, Puerto Rico; January, 2013 PART 7 Debate: Protein restriction is effective to retard CKD progression and to improve outcomes YES George A. Kaysen, MD NO Bertram L. Kasiske, MD Is intervention in periodontal disease in CKD worthwhile? Roberto Pecoits Filho, MD Hans-Dietrich Polaschegg Lecture: Is it technology or process that will improve dialysis outcomes? Richard A. Ward

June 30, 2013

Sethi

Brigham Board Review Course    Boston, MA; August, 2012 Membranoproliferative Glomerulonephritis Sanjeev Sethi, MD

Martin   Spiegel   Shenoy   Gutekunst

ISHD Hemodialysis University (Part 2)    Chicago, IL; September, 2012 PART 2. MINERAL BONE DISORDER MBD Case Presentations Kevin Martin, MB, and David M. Spiegel, MD What is the optimal dialysate calcium concentration? Peter Kotanko, MD Hemodialysis University – Optimal Dialysate Ca and Mg David M. Spiegel, MD Mineral Bone Disorder: Phosphorus, Calcium and Magnesium Lisa Gutekunst, MSEd

Nester   Levin   Canaud   Kupin

Advances in CKD 2013 (Part 6)    Renal Research Institute Rio Grande, Puerto Rico; January, 2013 PART 6 Multifaceted hemolytic uremic syndrome (HUS) in pediatrics Carla M. Nester, MD A perspective on the Frequent Hemodialysis Network trials: what are the practical lessons? Nathan W. Levin, MD Hemodiafiltration: what do the latest RCTs tell us? Bernard Canaud, MD Keynote Address: Do live kidney donors put themselves at measurable risk? Warren Kupin, MD

May 31, 2013

Appel

Brigham Board Review Course    Boston, MA; August, 2012 Glomerulonephritis: Lupus Nephritis for the Boards Gerald B. Appel, MD

Sands   Beathard   Shenoy   Brouwer

ISHD Hemodialysis University (Part 1)    Chicago, IL; September, 2012 PART 1. VASCULAR ACCESS Minimizing Catheter Use Jeffrey J. Sands, MD Building a Program to Reduce HD Catheter-Associated Infections Priti Patel, MD Chronic Complications Associated with Tunneled Catheters Gerald Beathard, MD AV Access - Placement and Maturation Surendra Shenoy, MD Interventional Procedures to Aid Maturation Gerald A. Beathard, MD Access Evaluation in the Dialysis Unit - Parts 1 and 2 Gerald A. Beathard, MD Best Practices in the Care of AV Fistula Deborah Brouwer, RN, CNN Establishing An Organized Approach To Vascular Access Jeffrey J. Sands, MD

Robinson   London   Kotanko   Wolf   Burkart   Gotch

Advances in CKD 2013 (Part 5)    Renal Research Institute Rio Grande, Puerto Rico; January, 2013 PART 5 PD DOPPS: Organization and early findings Bruce Robinson, MD The identification and effect on outcome of vascular calcification Gerard M. London, MD Roles of FGF23 in Mineral Metabolism and Cardiovascular Disease in CKD Myles Wolf, MD What are the optimal bicarbonate levels in HD and PD? John Burkart, MD Keynote Address: After 30 years of dialysis quantitation—where are we now? Frank Gotch, MD Can volume removal in dialysis become a science (or scientifically respectable)? Peter Kotanko, MD

April 30, 2013

Fogo   Appel     Campese   Vaziri   Bonilla-Felix

Advances in CKD 2013 (Part 4)    Renal Research Institute Rio Grande, Puerto Rico; January, 2013 PART 4 Approach to renal biopsy Agnes B. Fogo, MD New diagnostic tests and new therapies for idiopathic nephrotic syndrome Gerald B. Appel, MD Debate: Lipid management is effective in all stages of CKD (Yes) Vito M. Campese, MD (No) N.D. Vaziri, MD Peritoneal dialysis in the pediatric ICU setting: techniques, quantitations and outcomes Melvin Bonilla-Felix, MD

Karumanchi   August   Becker   Sabatine   Agarwal   Weir   Oparil

American Society of Hypertension Annual Scientific Meeting (Parts 11-14)    New York, NY; May, 2012 PARTS 11-14 Pathophysiology of Hypertension During Pregnancy Medicine S. Ananth Karumanchi, MD Clinical Management of Pre-eclampsia Phyllis August, MD Keynote Lecture: Development of Antithrombotic Therapies in Cardiovascular Medicine Richard C. Becker, MD Clinical Benefits of New Anti-thrombotic Therapies from a Trialist's Perspective Marc Sabatine, MD Debate 2: Blood Pressure in Hemodialysis Patients Should be Aggressively Lowered: Protagonist Rajiv Agarwal, MD Antagonist Matthew R. Weir, MD JNC-8 Suzanne Oparil, MD

March 31, 2013

Lacson   DeOreo   Maddux   Prosl   Kenley   Yu   McIntyre

Advances in CKD 2013 (Parts 2 and 3)    Renal Research Institute Rio Grande, Puerto Rico; January, 2013 PART 3 Quality Incentive Program (QIP) Eduardo Lacson, Jr., MD ESRD outlook for 2014 Peter B. DeOreo, MD Accountable Care for Renal Disease Franklin W. Maddux, MD PART 2 Ports for vascular access in dialysis Frank Prosl, MD Extracorporeal methods to reduce inflammation in acute sepsis Rodney S. Kenley, MS, MBA HIF-1 stabilizer drugs for the treatment of anemia K. Peony Yu, MD Keynote Address: Development and clinical use of remote ischaemic pre conditioning for cardioprotection Chris W. McIntyre, MD

Townsend   Wilkinson   Gorelick   Morgenstern   Macgregor   Staessen   Cushman   Elliott

American Society of Hypertension Annual Scientific Meeting (Parts 7-10)    New York, NY; May, 2012 PART 10 Structure and Function of the Arterial Wall: Clinical Applications Arterial Stiffness and Central Blood Pressure Raymond R. Townsend, MD Arterial Stiffness and Hypertension: Partners in Crime? Ian B. Wilkinson, MD PART 9 The Brain as the Target of Hypertension Effect of Hypertension on the Cerebral Circulation and Cognition Philip B. Gorelick, MD Hypertension Management During Acute Stroke Lewis B. Morgenstern, MD PART 8 Should there be Regulatory Steps to Lower Salt Intake? Protagonist Graham MacGregor, MD Antagonist Jan A. Staessen, MD PART 7 What Should Be the Goal Blood Pressure in Special Populations with Hypertension? Diabetes, Chronic Kidney Disease, Coronary Artery Disease, Heart Failure William C. Cushman, MD, FASH Antihypertensive Drugs: Is there a Best/Worst in Each Class? William J. Elliott, MD

February 28, 2013

Kotanko   Himmelfarb   Merchant   Usvyat   Maddux

Advances in CKD 2013 (Part 1)    Renal Research Institute Rio Grande, Puerto Rico; January, 2013 Welcome Peter Kotanko, MD The translation of clinical science to practice in nephrology and dialysis Jonathan Himmelfarb, MD A Technical Overview of Sorbent Technology Steve Merchant, PhD The MONitoring Dialysis Outcomes (MONDO) initiative: what is it and what have we learned so far? Len Usvyat, MCP Nutritional resilience—a novel concept Franklin W. Maddux, MD

Julius   Bakris   Desir   Sim   Reiffel   Deedwania   Berns   Peixoto   Taler   Textor   Carey   Viera

American Society of Hypertension Annual Scientific Meeting (Parts 2-6)    New York, NY; May, 2012 Renal Sympathetic Nerves, Hypertension, and Cardiovascular Disease Sympathetic Nervous System and Cardiovascular Outcomes Stevo Julius, MD Role of Sympathetic Fibers on Renal Function Gary V. Desir, MD Renal Denervation for Resistant Hypertension George L. Bakris, MD Renalase regulates blood pressure Drs. Gary Desir, Peili Wang, Lieqi Tang, and Heino Velazquez Comparative Outcomes in Resistant Hypertension John J. Sim, MD Hypertension Highlights 2012 - Part III: The Heart Atrial Arrhythmias—Pathogenesis and Treatment James A. Reiffel, MD New Insights into Preserved Systolic Function Heart Failure Prakash C. Deedwania, MD Hypertension Highlights 2012 - Part II: The Kidney Blood Pressure Monitoring in Chronic Kidney Disease Aldo J. Peixoto, MD Erythrocyte Stimulating Agents, Blood Pressure and Cardiovascular Risk Jeffrey S. Berns, MD Hypertension Highlights 2012 - Part I: The Artery Central Blood Pressure from the Framingham Experience Gary F. Mitchell, MD Hemodynamic Measurements to Guide Antihypertensive Therapy Sandra J. Taler, MD Theme II: Secondary Causes of Hypertension: An Update When to Consider Secondary Causes of Hypertension Anthony J. Viera, MD Adrenal Causes of Secondary Hypertension- Pheochromocytoma and Aldosteronoma Robert M. Carey, MD Renovascular Hypertension Stephen C. Textor, MD

Ross   Mishler   Work

ASDIN Annual Scientific Meeting (Part 15 - final)    New Orleans, LA; February, 2012 PART 15 Surgical Session Surgeon’s Perspective Prior to Creation of Vascular Access John R. Ross, MD New Surgical Techniques for Fistula Creation Rick Mishler, MD The Hero Device Update Jack Work, MD

Annual Dialysis Conference 2012 now in MP3

AUDIOFILE LIST (Annual Dialysis Conference 2012) (12 talks) PD Should be the First Modality for New Dialysis Patients Kunal Chaudhary, MD, and Jay Wish, MD Is Bundling Promoting PD? Anjali Saxena, MD, and Kurt Tarwater, MD Symposium on Peritoneal Dialysis in Children Jack Moncrief, MD, Mignon McCulloch, MD, Vimal Chadha, MD, Lynda Newman, RN, and Piotr Skrzypczyk, MD The Divalent Cautions and the Dialysis Patient: The Saga Never Ends Peter Kotanko, MD, Carl Kjellstrand, MD, and Georges Saab, MD

HDCN home /about our site / subscribe to key zone / register for free zone
update email address / subscription status / forget your password?